Our Science – Wang Website
Yisong Wang, Ph.D.
Selected Publications |
| 1)
Voortman J, Harada T, Chang RP, Killian JK, Suuriniemi M, Smith WI, Meltzer PS, Lucchi M, Wang Y, Giaccone G. Detection and Therapeutic Implications of c-Met Mutations in Small Cell Lung Cancer and Neuroendocrine Tumors. Curr. Pharm. Des. 19: 833-40, 2013. [Journal] |
| 2)
Petrini I, Meltzer PS, Zucali PA, Luo J, Lee C, Santoro A, Lee HS, Killian KJ, Wang Y, Tsokos M, Roncalli M, Steinberg SM, Wang Y, Giaccone G. Copy number aberrations of BCL2 and CDKN2A/B identified by array-CGH in thymic epithelial tumors. Cell Death Dis. 3: e351, 2012. [Journal] |
| 3)
Thomas A, Rajan A, Lopez-Chavez A, Wang Y, Giaccone G. From targets to targeted therapies and molecular profiling in non-small cell lung carcinoma. Ann. Oncol. 2012. [Journal] |
| 4)
Lee JH, Giovannetti E, Hwang JH, Petrini I, Wang Q, Voortman J, Wang Y, Steinberg SM, Funel N, Meltzer PS, Wang Y, Giaccone G. Loss of 18q22.3 Involving the Carboxypeptidase of Glutamate-like Gene Is Associated with Poor Prognosis in Resected Pancreatic Cancer. Clin. Cancer Res. 18: 524-33, 2012. [Journal] |
| 5)
Petrini P, French CA, Rajan A, Cameron MJ, Jaffe ES, Zucali PA, Xie J, Wang Y, Giaccone G. NUT rearrangement is uncommon in human thymic epithelial tumors. J Thorac Oncol. 7: 744-50, 2012. [Journal] |
| 6)
Komiya T, Thomas A, Khozin S, Rajan A, Wang Y, Giaccone G. Response to Crizotinib inROS1-Rearranged Non-Small-Cell Lung Cancer. J. Clin. Oncol. 30: 3425-6, 2012. [Journal] |
| 7)
Wang Y, Giaccone G. Challenges in cancer molecular targets and therapeutics. Front Oncol. 1: 4, 2011. [Journal] |
| 8)
Lee JH, Voortman J, Dingemans AM, Voeller DM, Pham T, Wang Y, Giaccone G. MicroRNA expression and clinical outcome of small cell lung cancer. PLoS ONE. 6: e21300, 2011. [Journal] |
| 9)
Harada T, Yatabe Y, Takeshita M, Koga T, Yano T, Wang Y, Giaccone G. Role and Relevance of TrkB Mutations and Expression in Non-Small Cell Lung Cancer. Clin. Cancer Res. 17: 2638-45, 2011. [Journal] |
| 10)
Giaccone G, Wang Y. Strategies for overcoming resistance to EGFR family tyrosine kinase inhibitors. Cancer Treat. Rev. 37: 456-64, 2011. [Journal] |
| Click Here to View Expanded Bibliography. |
This page was last updated on 2/12/2013.
